Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Thoracic Surgery

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 94 articles: HTML format

Single Articles

August 2024
1. MEDINA CK, Barnes SG, Felker GM, Mentz RJ, et al
   Severe obesity among patients with left ventricular assist devices.
   Am Heart J. 2024;274:130-133.
   PubMed     Abstract available
   
   
   
2. TERKELSEN CJ, Thim T, Freeman P, Dahl JS, et al
   Randomized comparison of TAVI valves: The Compare-TAVI trial.
   Am Heart J. 2024;274:84-94.
   PubMed     Abstract available
   
   
   
3. DUARTE VE, Yamamura K, Economy KE, Graf JA, et al
   The effects of pregnancy in subjects with repaired tetralogy of Fallot.
   Am Heart J. 2024;274:95-101.
   PubMed     Abstract available
   
   
   July 2024
4. YANG Y, Chu TC, Suthar D, Beshish AG, et al
   Association of patient-level characteristics with long-term outcomes after Fontan palliation: Rationale, design, and baseline characteristics of the Pediatric Cardiac Care Consortium Fontan cohort study.
   Am Heart J. 2024;273:111-120.
   PubMed     Abstract available
   
   
   June 2024
5. WU ZM, Kan J, Ye F, You W, et al
   PCSK9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Randomized, Double- Blind, Placebo-Controlled, Multicenter SHAWN Study.
   Am Heart J. 2024 Jun 26:S0002-8703(24)00157-1. doi: 10.1016/j.ahj.2024.
   PubMed     Abstract available
   
   
   May 2024
6. KIM Y, Park H, Yoon HJ, Suh J, et al
   Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH): Study Protocol for a Randomized Controlled Non-Inferiority Trial.
   Am Heart J. 2024 May 7:S0002-8703(24)00119-4. doi: 10.1016/j.ahj.2024.
   PubMed     Abstract available
   
   
   
7. ZHANG F, Tian M, Wang X, Zhang H, et al
   Rationale and design of a Single-center Randomized Trial to Compare the Graft Patency between the Radial Artery and the No-touch Saphenous Vein in Coronary Artery Bypass Grafting Surgery (GRAFT-CAB Study).
   Am Heart J. 2024 May 4:S0002-8703(24)00117-0. doi: 10.1016/j.ahj.2024.
   PubMed     Abstract available
   
   
   
8. LEMLEY BA, Okunowo O, Ampah SB, Wu L, et al
   Effect of patient factors, center, and era on Fontan timing: An observational study using the Pediatric Health Information Systems Database.
   Am Heart J. 2024;271:156-163.
   PubMed     Abstract available
   
   
   
9. GUO Y, Liu X, Li R, Ng S, et al
   Comparison of Down Sizing Strategy (HANGZHOU Solution) and Standard Annulus Sizing Strategy in type 0 bicuspid aortic stenosis patients undergoing transcatheter aortic valve replacement: Rationale and design of a randomized clinical trial.
   Am Heart J. 2024 May 1:S0002-8703(24)00098-X. doi: 10.1016/j.ahj.2024.
   PubMed     Abstract available
   
   
   April 2024
10. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
    Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
    Am Heart J. 2024 Apr 17:S0002-8703(24)00078-4. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
11. ETIWY M, Flannery LD, Li SX, Morrison FJ, et al
    Examining Lack of Referrals to Heart Valve Specialists as Mechanisms of Potential Underutilization of Aortic Valve Replacement.
    Am Heart J. 2024 Apr 13:S0002-8703(24)00093-0. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    March 2024
12. GUINOT PG, Desebbe O, Besch G, Guerci P, et al
    Prospective randomized double-blind study to evaluate the superiority of Vasopressin versus Norepinephrine in the management of the patient at renal risk undergoing cardiac surgery with cardiopulmonary bypass (NOVACC trial).
    Am Heart J. 2024 Mar 14:S0002-8703(24)00068-1. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
13. KRUCOFF M, Spirito A, Baber U, Sartori S, et al
    Ticagrelor With or Without Aspirin Following Percutaneous Coronary Intervention in High-Risk Patients With Concomitant Peripheral Artery Disease: a subgroup analysis of the TWILIGHT randomized clinical trial.
    Am Heart J. 2024 Mar 6:S0002-8703(24)00053-X. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
14. DOU D, Yuan S, Jia Y, Wang Y, et al
    The protocol of enhanced recovery after cardiac surgery in adult patients: a stepped wedge cluster randomized trial.
    Am Heart J. 2024 Mar 2:S0002-8703(24)00051-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
15. KIM M, Ahn JM, Kang DY, Kim MJ, et al
    Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial.
    Am Heart J. 2024;269:167-178.
    PubMed     Abstract available
    
    
    February 2024
16. ZHANG J, Kong XQ, Gao XF, Chen J, et al
    Transfemoral transcatheter aortic valve replacement with VitaFlow(TM) valve for pure native aortic regurgitation in patients with high surgical risk: Rationale and design of a prospective, multicenter, and randomized SEASON-AR trial.
    Am Heart J. 2024 Feb 25:S0002-8703(24)00049-8. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
17. KEDHI E, Rroku A, Hermanides RS, Dambrink JH, et al
    TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention versus Conventional Surgical Aortic Valve Replacement and Coronary Bypass Grafting for Treatment of Patients with Aortic Valve Stenosis and M
    Am Heart J. 2024 Feb 1:S0002-8703(24)00019-X. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    January 2024
18. ASHWAT E, Brown JA, Yousef S, Ahmad D, et al
    Radial Artery versus Right Internal Mammary Artery as a Second Conduit during Coronary Artery Bypass Grafting.
    Am Heart J. 2024 Jan 20:S0002-8703(24)00015-2. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
19. JAMMOUL N, Dupasquier V, Akodad M, Meunier PA, et al
    Long-term follow-up of balloon-expandable valves according to the implantation strategy: insight from the DIRECTAVI trial.
    Am Heart J. 2024 Jan 20:S0002-8703(24)00014-0. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    December 2023
20. HEGEMAN RRMJJ, van Ginkel DJ, Langle S, Timmers L, et al
    Preoperative CT-imaging with patient-specific computer simulation in transcatheter aortic valve implantation: Design and rationale of the GUIDE-TAVI trial.
    Am Heart J. 2023 Dec 30:S0002-8703(23)00360-5. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
21. GENEREUX P, Schwartz A, Oldemeyer B, Cohen DJ, et al
    Design and Rationale of the Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients with AsYmptomatic Severe Aortic Stenosis: The EARLY TAVR Trial.
    Am Heart J. 2023 Dec 4:S0002-8703(23)00326-5. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
22. DILLEN DMM, Vlaar PJ, Vermeer AJE, Paradies V, et al
    Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study.
    Am Heart J. 2023;266:168-175.
    PubMed     Abstract available
    
    
    November 2023
23. STRANGE JE, Nouhravesh N, Schou M, Christensen DM, et al
    High-risk admission prior to transcatheter aortic valve replacement and subsequent outcomes: Preceding events and outcomes after TAVR.
    Am Heart J. 2023 Nov 14:S0002-8703(23)00311-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
24. FOOTE HP, Thibault D, Gonzalez CD, Hill GD, et al
    Center-level factors associated with shorter length of stay following stage 1 palliation: An analysis of the national pediatric cardiology quality improvement collaborative registry.
    Am Heart J. 2023;265:143-152.
    PubMed     Abstract available
    
    
    October 2023
25. BARON SJ, Ryan MP, Chikermane SG, Thompson C, et al
    Long-Term Risk of Reintervention after Transcatheter Aortic Valve Replacement.
    Am Heart J. 2023 Oct 21:S0002-8703(23)00296-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
26. BAINEY KR, Wood DA, Bossard M, Campo G, et al
    Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease (COMPLETE-AGE).
    Am Heart J. 2023 Oct 21:S0002-8703(23)00297-1. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    September 2023
27. CHEEMA HA, Khan AA, Ahmad AH, Khan AA, et al
    Prophylactic corticosteroids for cardiac surgery in children: A systematic review and meta-analysis.
    Am Heart J. 2023 Sep 14:S0002-8703(23)00279-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
28. OHUCHI H, Mori A, Kurosaki K, Shiraishi I, et al
    Prevalence and clinical correlates and characteristics of "Super Fontan".
    Am Heart J. 2023;263:93-103.
    PubMed     Abstract available
    
    
    
29. O'BYRNE ML, Song L, Huang J, Lemley B, et al
    Attributable mortality benefit of digoxin treatment in hypoplastic left heart syndrome after the Norwood operation: An instrumental variable-based analysis using data from the Pediatric Health Information Systems Database.
    Am Heart J. 2023;263:35-45.
    PubMed     Abstract available
    
    
    July 2023
30. PARK S, Rha SW, Choi BG, Kim W, et al
    Efficacy and Safety of Cilostazol-Based Triple Antiplatelet Therapy Compared with Clopidogrel-Based Dual Antiplatelet Therapy in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Multicenter, Rando
    Am Heart J. 2023 Jul 3:S0002-8703(23)00172-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    June 2023
31. SEGUCHI M, Aytekin A, Steiger L, Nicol P, et al
    Near-infrared Spectroscopy-Intravascular Ultrasound to Improve Assessment of Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic Valve Implantation (The IMPACTavi registry): Design and Rationale.
    Am Heart J. 2023 Jun 12:S0002-8703(23)00159-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
32. MADSEN CL, Park-Hansen J, Irmukhamedov A, Carranza CL, et al
    The Left Atrial Appendage Closure by Surgery-2 (LAACS-2) trial protocol Rationale and design of a randomized multicenter trial investigating if left atrial appendage closure prevents stroke in patients undergoing open-heart surgery irrespective of pre
    Am Heart J. 2023 Jun 9:S0002-8703(23)00147-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
33. BUJAK K, Vidal-Cales P, Gabani R, Rinaldi R, et al
    Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study.
    Am Heart J. 2023 Jun 4:S0002-8703(23)00141-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
34. SHECHTER A, Koren O, Skaf S, Makar M, et al
    Transcatheter Edge-to-Edge Repair for Chronic Functional Mitral Regurgitation in Patients with Very Severe Left Ventricular Dysfunction.
    Am Heart J. 2023 Jun 3:S0002-8703(23)00138-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
35. STAHL A, Havers-Borgersen E, Ostergaard L, Petersen JK, et al
    Hemodialysis and its impact on Patient Characteristics, Microbiology, Cardiac Surgery, and Mortality in Infective Endocarditis.
    Am Heart J. 2023 Jun 2:S0002-8703(23)00135-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    May 2023
36. BEGUN X, Butt JH, Kristensen SL, Weeke PE, et al
    Patient Characteristics and Long-term Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation in a Failed Surgical Prosthesis versus in a Native Valve: A Danish nationwide study.
    Am Heart J. 2023 May 11:S0002-8703(23)00118-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
37. SELAMET TIERNEY ES, Palaniappan L, Leonard M, Long J, et al
    Design and rationale of re-energize fontan: Randomized exercise intervention designed to maximize fitness in fontan patients.
    Am Heart J. 2023;259:68-78.
    PubMed     Abstract available
    
    
    April 2023
38. LAURIDSEN MD, Valentin JB, Strange JE, Jacobsen PA, et al
    Mortality in patients with chronic obstructive pulmonary disorder undergoing transcatheter aortic valve replacement: The importance of chronic obstructive pulmonary disease exacerbation.
    Am Heart J. 2023;262:100-109.
    PubMed     Abstract available
    
    
    
39. COISNE A, Aghezzaf S, Butruille L, Woitrain E, et al
    Incidence, Source, and Prognostic Impact of Major Bleeding Across the Spectrum of Aortic Stenosis.
    Am Heart J. 2023 Apr 24:S0002-8703(23)00099-6. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
40. RIKKEN SA, Bor WL, Selvarajah A, Zheng KL, et al
    Pre-Percutaneous Coronary Intervention Zalunfiban Dose-Response Relationship to Target Vessel Blood Flow at Initial Angiogram in ST-Elevation Myocardial Infarction - A Post Hoc Analysis of the Cel-02 Phase IIa Study.
    Am Heart J. 2023 Apr 21:S0002-8703(23)00096-0. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
41. GRIFFITHS RI, Cavalcante R, McGovern AM, Bhave A, et al
    Cost to Medicare of Acute Kidney Injury in Percutaneous Coronary Intervention.
    Am Heart J. 2023 Apr 2:S0002-8703(23)00075-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
42. FU G, Zhou Z, Jian B, Huang S, et al
    Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:177-185.
    PubMed     Abstract available
    
    
    
43. DEMIREL C, Tomii D, Heg D, Okuno T, et al
    Incidental detection of malignancy during pre-procedural workup for transcatheter aortic valve implantation: a longitudinal cohort study.
    Am Heart J. 2023 Apr 1:S0002-8703(23)00072-8. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    March 2023
44. DESCAMPS R, Amour J, Besnier E, Bougle A, et al
    Perioperative individualized hemodynamic optimization according to baseline mean arterial pressure in cardiac surgery patients: Rationale and design of the OPTIPAM randomized trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00067-4. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
45. RONG LQ, Franco AD, Rahouma M, Dimagli A, et al
    Postoperative pericardial effusion, pericardiotomy and atrial fibrillation: an explanatory analysis of the PALACS trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00063-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
46. GAUTIER A, Roffi M, Laanmets P, Munir S, et al
    Complementary evidence on the performance of coronary stents generated by a randomized controlled trial and a worldwide registry.
    Am Heart J. 2023 Mar 15:S0002-8703(23)00061-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    February 2023
47. ALMOND CS, Sleeper LA, Rossano JW, Bock MJ, et al
    The TEAMMATE Trial: Study Design and Rationale Tacrolimus and Everolimus Against TACROLIMUS and MMF in Pediatric Heart Transplantation Using the Major Adverse Transplant Event (MATE) Score.
    Am Heart J. 2023 Feb 22:S0002-8703(23)00038-8. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
48. PARK S, Rha SW, Choi BG, Cho JH, et al
    Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00026-1. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
49. CONEN D, Popova E, Wang MK, Chan MTV, et al
    Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00025-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    January 2023
50. MALM CJ, Alfredsson J, Erlinge D, Gudbjartsson T, et al
    Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial.
    Am Heart J. 2023 Jan 18:S0002-8703(23)00018-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
51. SAITO Y, Inohara T, Kohsaka S, Wada H, et al
    Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide J-PCI registry.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00017-0. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
52. HAVERS-BORGERSEN E, Butt JH, Strange J, Carranza CL, et al
    Mortality and Rehospitalization after Mitral Valve Surgery as a Function of Age and Key Comorbidities.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00016-9. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    December 2022
53. CUBEDDU RJ, Murphy SME, Asher CR, Garcia SA, et al
    Association of ACEI/ARB and Statin Prescribing Patterns with Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings from Real-World Claims Data.
    Am Heart J. 2022 Dec 31:S0002-8703(22)00333-7. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
54. RIKKEN SAOF, Selvarajah A, Hermanides RS, Coller BS, et al
    Pre-hospital treatment with zalunfiban (RUC-4) in patients with ST- Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Rationale and design of the CELEBRATE trial.
    Am Heart J. 2022 Dec 30:S0002-8703(22)00336-2. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
55. SKIBNIEWSKI M, Venetsanos D, Ahlsson A, Batra G, et al
    Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry.
    Am Heart J. 2022 Dec 5:S0002-8703(22)00321-0. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
56. GOLDBERG CS, Gaynor JW, Mahle WT, Ravishankar C, et al
    The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptations.
    Am Heart J. 2022;254:216-227.
    PubMed     Abstract available
    
    
    
57. TEHRANI DM, Kim JS, Hsu JJ, Nsair A, et al
    Early trends in cardiac allograft vasculopathy after implementation of the 2018 donor heart allocation policy in the United States.
    Am Heart J. 2022;254:23-29.
    PubMed     Abstract available
    
    
    
58. MORI M, Mark DB, Khera R, Lin H, et al
    Identifying quality of life outcome patterns to inform treatment choices in ischemic cardiomyopathy.
    Am Heart J. 2022;254:12-22.
    PubMed     Abstract available
    
    
    November 2022
59. DE WINTER RW, Walsh SJ, Hanratty CG, Spratt JC, et al
    Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery: Rationale and Design of the Multicenter, Randomized PROCTOR Trial.
    Am Heart J. 2022 Nov 18:S0002-8703(22)00296-4. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
60. NUIS RJ, van Belle E, Teles R, Blackman D, et al
    BA lloon Expandable vs. SElf Expanding Transcatheter VaLve for Degenerated BioprosthesIs: Design and Rationale of the BASELINE Trial.
    Am Heart J. 2022 Nov 18:S0002-8703(22)00295-2. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available
    
    
    
61. SAVITZ ST, Leong T, Sung SH, Kitzman DW, et al
    Predicting Short-term Outcomes After Transcatheter Aortic Valve Replacement for Aortic Stenosis.
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00286.
    PubMed     Abstract available
    
    
    October 2022
62. CHUNG M, Butala NM, Faridi KF, Almarzooq ZI, et al
    Days at Home after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients.
    Am Heart J. 2022 Oct 26. pii: S0002-8703(22)00275.
    PubMed     Abstract available
    
    
    
63. NELSON AJ, Inohara T, Rao SV, Kaltenbach LA, et al
    Comparing the classification of Percutaneous Coronary Interventions using the 2012 and 2017 Appropriate Use Criteria: Insights from 245,196 patients in the NCDR CathPCI registry.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00199.
    PubMed     Abstract available
    
    
    
64. OLIVA A, Castiello DS, Franzone A, Condorelli G, et al
    P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex Vs. Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00201.
    PubMed     Abstract available
    
    
    
65. SABBAH M, Veien K, Niemela M, Freeman P, et al
    Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third Nordic Aortic Valve Intervention Trial - NOTION-3.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00204.
    PubMed     Abstract available
    
    
    
66. SPEHAR SM, Seth M, Henke P, Alaswad K, et al
    Race and Outcomes after Percutaneous Coronary Intervention: Insights from the Michigan Blue Cross Blue Shield Cardiovascular Consortium.
    Am Heart J. 2022 Oct 7. pii: S0002-8703(22)00196.
    PubMed     Abstract available
    
    
    September 2022
67. MYLONAS KS, Tasoudis PT, Pavlopoulos D, Kanakis M, et al
    Aortic valve neocuspidization using the Ozaki technique: A meta-analysis of reconstructed patient-level data.
    Am Heart J. 2022 Sep 14. pii: S0002-8703(22)00186.
    PubMed     Abstract available
    
    
    
68. HERSCOVICI DM, Boggs KM, Cash RE, Espinola JA, et al
    Development of a Unified National Database of Primary Percutaneous Coronary Intervention Centers with Co-located Emergency Departments, 2020.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00188.
    PubMed     Abstract available
    
    
    August 2022
69. PARLOW S, Di Santo P, Jung RG, Fam N, et al
    Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock - Design and Rationale of the CAPITAL MINOS Trial.
    Am Heart J. 2022 Aug 21. pii: S0002-8703(22)00169.
    PubMed     Abstract available
    
    
    
70. KIKANO S, Breeyear J, Aka I, Edwards TL, et al
    Association Between Nitric Oxide Synthase 3 Genetic Variant and Acute Kidney Injury Following Pediatric Cardiac Surgery.
    Am Heart J. 2022 Aug 18. pii: S0002-8703(22)00164.
    PubMed     Abstract available
    
    
    
71. SALZMANN S, Laferton JAC, Shedden-Mora MC, Horn N, et al
    Pre-surgery optimization of patients' expectations to improve outcome in heart surgery: Study protocol of the randomized controlled multi-center PSY-HEART-II trial.
    Am Heart J. 2022 Aug 5. pii: S0002-8703(22)00161.
    PubMed     Abstract available
    
    
    June 2022
72. HOLLANDER SA, Barkoff L, Giacone H, Adamson GT, et al
    Risk Factors and Outcomes of Sudden Cardiac Arrest in Pediatric Heart Transplant Recipients.
    Am Heart J. 2022 Jun 12. pii: S0002-8703(22)00127.
    PubMed     Abstract available
    
    
    
73. TOMII D, Pilgrim T, Heg D, Reineke D, et al
    Reply: Correlation of aortic root dimensions in patients undergoing transcatheter aortic valve implantation.
    Am Heart J. 2022;248:166-168.
    PubMed    
    
    
    
74. GUPTA K, Lee JC
    Assessment of sinus of valsalva dimensions before TAVI: An independent predictor of worse outcomes?
    Am Heart J. 2022;248:165.
    PubMed    
    
    
    May 2022
75. PARK DY, Wang P, An S, Grimshaw AA, et al
    Shortening the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Systematic Review and Meta-analysis: Shortening DAPT after PCI for ACS.
    Am Heart J. 2022 May 30. pii: S0002-8703(22)00113.
    PubMed     Abstract available
    
    
    
76. PAHUJA M, Case BC, Molina EJ, Waksman R, et al
    Overview of the FDA's Circulatory System Devices Panel virtual meeting on the TransMedics Organ Care System (OCS) Heart - portable extracorporeal heart perfusion and monitoring system.
    Am Heart J. 2022;247:90-99.
    PubMed     Abstract available
    
    
    April 2022
77. GARG A, Rout A, Farhan S, Waxman S, et al
    Dual Antiplatelet Therapy Duration after Percutaneous Coronary Intervention using Drug Eluting Stents in High Bleeding Risk Patients: A Systematic Review and Meta-analysis.
    Am Heart J. 2022 Apr 15. pii: S0002-8703(22)00076.
    PubMed     Abstract available
    
    
    
78. BAGIELLA E, Puskas JD, Moskowitz AJ, Gelijns AC, et al
    Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts.
    Am Heart J. 2022;246:12-20.
    PubMed     Abstract available
    
    
    March 2022
79. VERMA S, Rathwell S, Fremes S, Zheng Y, et al
    Associated Factors and Clinical Outcomes in Mechanical Circulatory Support use in Patients Undergoing High Risk On-Pump Cardiac Surgery: Insights from the LEVO-CTS trial.
    Am Heart J. 2022 Mar 6. pii: S0002-8703(22)00046.
    PubMed     Abstract available
    
    
    February 2022
80. O'NEILL WW, Anderson M, Burkhoff D, Grines CL, et al
    Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF.
    Am Heart J. 2022 Feb 19. pii: S0002-8703(22)00039.
    PubMed     Abstract available
    
    
    
81. LINDER M, Higgen FL, Voigtlander L, Weimann J, et al
    Stroke events after transcatheter aortic valve implantation: Temporal relationships and affected brain regions.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00030.
    PubMed     Abstract available
    
    
    January 2022
82. OTOWA K, Kohsaka S, Sawano M, Matsuura S, et al
    One-year Outcome after Percutaneous Coronary Intervention in Nonagenarians: Insights from the J-PCI OUTCOME Registry.
    Am Heart J. 2022 Jan 8. pii: S0002-8703(22)00004.
    PubMed     Abstract available
    
    
    
83. TERTULIEN T, Roberts MB, Eaton CB, Cene CW, et al
    Association Between Race/Ethnicity and Income on the Likelihood of Coronary Revascularization Among Postmenopausal Women with Acute Myocardial Infarction: Women's Health Initiative Study.
    Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00496.
    PubMed     Abstract available
    
    
    
84. HERRMANN HC, Abdel-Wahab M, Attizzani GF, Batchelor W, et al
    Rationale and design of the SMall Annuli Randomized To Evolut or SAPIEN Trial (SMART Trial).
    Am Heart J. 2022;243:92-102.
    PubMed     Abstract available
    
    
    
85. BUTALA NM, Song Y, Shen C, Cohen DJ, et al
    Effect of intensive versus limited monitoring on clinical trial conduct and outcomes: A randomized trial.
    Am Heart J. 2022;243:77-86.
    PubMed     Abstract available
    
    
    December 2021
86. CHRISTENSEN DM, Schjerning AM, Sindet-Pedersen C, Lamberts M, et al
    Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a nationwide registry-based study.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00471.
    PubMed     Abstract available
    
    
    November 2021
87. I D, Okuno T, Heg D, Grani C, et al
    Sinus of Valsalva Dimension and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: SOV dilatation in TAVI patients.
    Am Heart J. 2021 Nov 14. pii: S0002-8703(21)00447.
    PubMed     Abstract available
    
    
    
88. HUANG D, Wu H, Zhou J, Zhong X, et al
    Intravenous Nicorandil During Primary Percutaneous Coronary intervention in Patients with ST-Elevation Myocardial Infarction: Rationale and Design of the CLinical Efficacy and sAfety of intravenous Nicorandil (CLEAN) trial.
    Am Heart J. 2021 Nov 13. pii: S0002-8703(21)00448.
    PubMed     Abstract available
    
    
    
89. KOSHY AN, Dinh DT, Fulcher J, Brennan AL, et al
    Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.
    Am Heart J. 2021 Nov 12. pii: S0002-8703(21)00449.
    PubMed     Abstract available
    
    
    
90. YEH RW, Bachinsky W, Stoler R, Bateman C, et al
    Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis.
    Am Heart J. 2021;241:101-107.
    PubMed     Abstract available
    
    
    October 2021
91. PICCINI JP, Ahlsson A, Dorian P, Gillinov MA, et al
    Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study.
    Am Heart J. 2021 Oct 20. pii: S0002-8703(21)00366.
    PubMed     Abstract available
    
    
    September 2021
92. STRANGE JE, Sindet-Pedersen C, Gislason GH, Torp-Pedersen C, et al
    Title: Temporal trends in utilization of transcatheter aortic valve replacement and patient characteristics: a nationwide study.
    Am Heart J. 2021 Sep 26. pii: S0002-8703(21)00239.
    PubMed     Abstract available
    
    
    
93. CLARK KA, Chouairi F, Kay B, Reinhardt SW, et al
    Trends in Transcatheter and Surgical Aortic Valve Replacement in the United States, 2008-2018.
    Am Heart J. 2021 Sep 24. pii: S0002-8703(21)00232.
    PubMed     Abstract available
    
    
    June 2021
94. YONG CM, Spinelli KJ, Chiu ST, Jones B, et al
    Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.
    Am Heart J. 2021 Jun 25. pii: S0002-8703(21)00167.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Thoracic Surgery is free of charge.